Amy Damask

3.6k citations

14 papers · 492 indexed · h-index 9

Impact in

Physiology
- Asthma and respiratory diseases
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies

Papers in ⓘ

Genetics 6
- Genetic Associations and Epidemiology 4
- Chronic Lymphocytic Leukemia Research 1
Physiology 4
- Asthma and respiratory diseases 4

Co-authors: Scott T. Weiss (4 shared papers)Kelan G. Tantisira (4 shared papers)Augusto A. Litonjua (2 shared papers)Jessica Lasky‐Su (3 shared papers)Charles Paulding (6 shared papers)Mousheng Xu (1 shared paper)Poulabi Banerjee (2 shared papers)John D. Overton (4 shared papers)
Journals: Journal of Clinical Oncology (3 papers)Annals of the Rheumatic Diseases (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)Circulation Genomic and Precision Medicine (1 paper)Human Molecular Genetics (1 paper)
Partner nations: United States France Canada

In The Last Decade

Amy Damask

14 papers receiving 482 citations

Peers

Countries citing papers authored by Amy Damask

Since Specialization

Citations

This map shows the geographic impact of Amy Damask's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Damask with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Damask more than expected).

Fields of papers citing papers by Amy Damask

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Damask. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Damask. The network helps show where Amy Damask may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Damask, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Damask Line = papers co-authored together Amy Damask links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial Circulation ·Amy Damask, Philippe Gabríel Steg, Gregory G. Schwartz, Michael Szarek, Emil Hagström, Lina Badimón, M. John Chapman, Cathérine Boileau, Sotirios Tsimikas, Henry N. Ginsberg, Poulabi Banerjee, Garen Manvelian, Robert Pordy, Sibylle Hess, John D. Overton, Luca A. Lotta, George D. Yancopoulos, Gonçalo R. Abecasis, Aris Baras, Charles Paulding	2019	146
2	Genome-wide Association Identifies the T Gene as a Novel Asthma Pharmacogenetic Locus American Journal of Respiratory and Critical Care Medicine ·Kelan G. Tantisira, Amy Damask, Stanley J. Szefler, Brooke Schuemann, Amy Markezich, Jessica Lasky‐Su, Barbara J. Klanderman, Jody Sylvia, Rongling Wu, Fernando D. Martínez, Homer A. Boushey, Vernon M. Chinchilli, Dave Mauger, Scott T. Weiss, Elliot Israel	2012	64
3	Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers BMC Medical Genetics ·Mousheng Xu, Kelan G. Tantisira, Ann Chen Wu, Augusto A. Litonjua, J Chu, Blanca E. Himes, Amy Damask, Scott T. Weiss	2011	62
4	Correlation of molecular alterations with efficacy of everolimus in hormone-receptor–positive (HR+), HER2-negative advanced breast cancer: Preliminary results from BOLERO-2. Journal of Clinical Oncology ·Gabriel N. Hortobágyi, Martine Piccart, Hope S. Rugo, Howard A. Burris, Mario Campone, Shinzaburo Noguchi, Alejandra Perez, Ines Deleu, Mikhail Shtivelband, Louise Provencher, Norikazu Masuda, Shaker R. Dakhil, Ian C. Anderson, David Chen, Amy Damask, Alan Huang, Robert McDonald, Tanya Taran, Tarek Sahmoud, José Baselga	2013	59
5	Correlation of molecular alterations with efficacy of everolimus in hormone receptor–positive, HER2-negative advanced breast cancer: Results from BOLERO-2. Journal of Clinical Oncology ·Gabriel N. Hortobágyi, Martine Piccart, Hope S. Rugo, Howard A. Burris, Mario Campone, Shinzaburo Noguchi, Alejandra Perez, Ines Deleu, Mikhail Shtivelband, Louise Provencher, Norikazu Masuda, Shaker R. Dakhil, Ian Anderson, David Chen, Amy Damask, Alan Huang, Robert McDonald, Tanya Taran, Tarek Sahmoud, José Baselga	2013	54
6	Genome-wide association analysis of circulating vitamin D levels in children with asthma Human Genetics ·Jessica Lasky‐Su, Nancy E. Lange, John M. Brehm, Amy Damask, Manuel Soto-Quirós, Lydiana Ávila, Juan C. Celedón, Glorisa Canino, Michelle M. Cloutier, Bruce W. Hollis, Scott T. Weiss, Augusto A. Litonjua	2012	45
7	Genome-Wide Association Study of Short-Acting β2-Agonists. A Novel Genome-Wide Significant Locus on Chromosome 2 near ASB3 American Journal of Respiratory and Critical Care Medicine ·Elliot Israel, Jessica Lasky‐Su, Amy Markezich, Amy Damask, Stanley J. Szefler, Brooke Schuemann, Barbara J. Klanderman, Jody Sylvia, Shamsah Kazani, Rongling Wu, Fernando D. Martínez, Homer A. Boushey, Vernon M. Chinchilli, Dave Mauger, Scott T. Weiss, Kelan G. Tantisira	2015	24
8	Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysis Human Molecular Genetics ·Weiliang Qiu, Angela J. Rogers, Amy Damask, Benjamin A. Raby, Barbara J. Klanderman, Qing Duan, Shiva Tyagi, Simin Niu, Christopher D. Anderson, Ellen Cahir-McFarland, Thomas J. Mariani, Vincent J. Carey, Kelan G. Tantisira	2014	22
9	Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial Circulation Genomic and Precision Medicine ·William A. Murphy, Nan Lin, Amy Damask, Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek, Poulabi Banerjee, Sergio Fazio, Garen Manvelian, Robert Pordy, Alan R. Shuldiner, Charles Paulding	2022	8
10	UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab The Pharmacogenomics Journal ·Nan Lin, Amy Damask, Anita Boyapati, Jennifer D. Hamilton, Sara Hamon, Nils Ternès, Michael C. Nivens, John S. Penn, Alexander Lopez, Jeffrey G. Reid, John D. Overton, Alan R. Shuldiner, Gonçalo R. Abecasis, Aris Baras, Charles Paulding	2022	2
11	ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2 Investigative Ophthalmology & Visual Science ·Robyn H. Guymer, Rufino Silva, Mercedeh Ghadessi, Sergio Leal, Isabella Gashaw, Amy Damask, Charles Paulding, Kay D. Rittenhouse	2024	2
12	FRI0228 Ugt1a1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab Annals of the Rheumatic Diseases ·Amy Damask, Anita Boyapati, JD Hamilton, Sara Hamon, Caroline Paccard, Janie Parrino, Janet van Adelsberg, NM Graham, John S. Penn, Alex Lopez, Jeffrey D. Reid, John D. Overton, Aris Baras, Alan R. Shuldiner, Charles Paulding	2017	2
13	SAT0179 The ASP358ALA variant in the IL6R gene is significantly associated with differences in soluble IL-6R protein levels but not with differences in sarilumab response in rheumatoid arthritis (RA) patients Annals of the Rheumatic Diseases ·Amy Damask, Anita Boyapati, JD Hamilton, Sara Hamon, Caroline Paccard, Janie Parrino, Janet van Adelsberg, NM Graham, John S. Penn, Alex Lopez, Jeffrey D. Reid, John D. Overton, Aris Baras, Alan R. Shuldiner, Charles Paulding	2017	1
14	Correlation of molecular alterations with efficacy of everolimus in hormone-receptor–positive, HER2-negative advanced breast cancer: Results from BOLERO-2. Journal of Clinical Oncology ·Hope S. Rugo, Gabriel N. Hortobágyi, Martine Piccart, Howard A. Burris, Mario Campone, Shinzaburo Noguchi, Alejandra Perez, Ines Deleu, Mikhail Shtivelband, Louise Provencher, Norikazu Masuda, Shaker R. Dakhil, Ian Anderson, David Chen, Amy Damask, Alan Huang, Robert McDonald, Tanya Taran, Tarek Sahmoud, José Baselga	2013	1

About Amy Damask

Amy Damask is a scholar working on Genetics, Physiology, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 492 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Genetic Associations and Epidemiology (4 papers), Cancer Treatment and Pharmacology (2 papers), Respiratory and Cough-Related Research (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chronic Lymphocytic Leukemia Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Physiology (145 citations), Pulmonary and Respiratory Medicine (151 citations), Genetics (128 citations), Health Informatics (6 citations) and Cancer Research (62 citations). Amy Damask has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Scott T. Weiss, Kelan G. Tantisira, Augusto A. Litonjua, Jessica Lasky‐Su, Charles Paulding, Mousheng Xu, Poulabi Banerjee, John D. Overton, Gregory G. Schwartz and Michael Szarek. Their work appears in journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases, American Journal of Respiratory and Critical Care Medicine, Circulation Genomic and Precision Medicine and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact